Xiao-Jing Du
Impact in
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Colorectal Cancer Treatments and Studies
- Inflammatory Biomarkers in Disease Prognosis
- Lung Cancer Research Studies
Papers in
-
- Head and Neck Cancer Studies 5
-
- Lung Cancer Treatments and Mutations 1
- Brain Metastases and Treatment 1
- Co-authors
- Ying Sun (7 shared papers)Jun Ma (7 shared papers)Ai-Hua Lin (6 shared papers)Ling‐Long Tang (6 shared papers)Lei Chen (5 shared papers)Wen-Fei Li (4 shared papers)Guan‐Qun Zhou (2 shared papers)Yu‐Pei Chen (2 shared papers)
- Journals
- Journal of Cancer (3 papers)Scientific Reports (1 paper)PLoS ONE (1 paper)BMJ (1 paper)Oral Oncology (1 paper)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Xiao-Jing Du
9 papers receiving 682 citations
Xiao-Jing Du's Hit Papers
Peers
Comparison fields: 5 of 62
- Otorhinolaryngology 135
- Oncology 410
- Immunology 76
- Genetics 35
- Pulmonary and Respiratory Medicine 91
Countries citing papers authored by Xiao-Jing Du
This map shows the geographic impact of Xiao-Jing Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao-Jing Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao-Jing Du more than expected).
Fields of papers citing papers by Xiao-Jing Du
This network shows the impact of papers produced by Xiao-Jing Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao-Jing Du. The network helps show where Xiao-Jing Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiao-Jing Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-analysis Hit paper breakdown → | 2018 | 426 |
| 2 | 2015 | 66 | |
| 3 | 2018 | 61 | |
| 4 | 2017 | 37 | |
| 5 | 2015 | 31 | |
| 6 | 2019 | 27 | |
| 7 | 2016 | 26 | |
| 8 | 2019 | 9 | |
| 9 | 2016 | 6 |
About Xiao-Jing Du
Xiao-Jing Du is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Genetics, having authored 9 papers that have together received 689 indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (5 papers), Cancer Immunotherapy and Biomarkers (1 paper), Lung Cancer Treatments and Mutations (1 paper), Cancer-related gene regulation (1 paper), Salivary Gland Tumors Diagnosis and Treatment (1 paper), Glioma Diagnosis and Treatment (1 paper), Brain Metastases and Treatment (1 paper) and Cancer, Hypoxia, and Metabolism (1 paper). The work is most often cited by research in Otorhinolaryngology (135 citations), Oncology (410 citations), Immunology (76 citations), Genetics (35 citations) and Pulmonary and Respiratory Medicine (91 citations). Xiao-Jing Du has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Ying Sun, Jun Ma, Ai-Hua Lin, Ling‐Long Tang, Lei Chen, Wen-Fei Li, Guan‐Qun Zhou, Yu‐Pei Chen, Yan-Ping Mao and Qing Liu. Their work appears in journals such as Journal of Cancer, Scientific Reports, PLoS ONE, BMJ and Oral Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.